STÁREK, Zdeněk, František LEHAR, Jiří JEŽ, Martin PEŠL, Petr NEUZIL, Lucie SEDIVA, Jan PETRU, Libor DUJKA, Moritoshi FUNASAKO, Josef KAUTZNER, Petr PEICHL, Bashar ALDHOON, Jean-Paul ALBENQUE, Stephane COMBES, Serge BOVEDA, Srinivas R. DUKKIPATI a Vivek Y. REDDY. Efficacy and safety of novel temperature-controlled radiofrequency ablation system during pulmonary vein isolation in patients with paroxysmal atrial fibrillation: TRAC-AF study. Journal of interventional cardiac electrophysiology. Dordrecht: Springer, 2022, roč. 64, č. 2, s. 375-381. ISSN 1383-875X. Dostupné z: https://dx.doi.org/10.1007/s10840-021-00986-0.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Efficacy and safety of novel temperature-controlled radiofrequency ablation system during pulmonary vein isolation in patients with paroxysmal atrial fibrillation: TRAC-AF study
Autoři STÁREK, Zdeněk (203 Česká republika, garant, domácí), František LEHAR (203 Česká republika, domácí), Jiří JEŽ (203 Česká republika, domácí), Martin PEŠL (203 Česká republika, domácí), Petr NEUZIL (203 Česká republika), Lucie SEDIVA (203 Česká republika), Jan PETRU (203 Česká republika), Libor DUJKA (203 Česká republika), Moritoshi FUNASAKO, Josef KAUTZNER (203 Česká republika), Petr PEICHL (203 Česká republika), Bashar ALDHOON, Jean-Paul ALBENQUE, Stephane COMBES, Serge BOVEDA, Srinivas R. DUKKIPATI a Vivek Y. REDDY.
Vydání Journal of interventional cardiac electrophysiology, Dordrecht, Springer, 2022, 1383-875X.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30201 Cardiac and Cardiovascular systems
Stát vydavatele Nizozemské království
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 1.800
Kód RIV RIV/00216224:14110/22:00124969
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1007/s10840-021-00986-0
UT WoS 000658058700001
Klíčová slova anglicky Catheter radiofrequency ablation; Atrial fibrillation; Diamond tip irrigated catheter; Temperature contol ablation; High-resolution electrograms; Safety and efficacy
Štítky 14110115, 14110513, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 16. 1. 2023 12:17.
Anotace
Background and purpose Saline-irrigated radiofrequency ablation (RFA) for atrial fibrillation (AF) is limited by the absence of reliable thermal feedback limiting the utility of temperature monitoring for power titration. The DiamondTemp (DT) ablation catheter was designed to allow efficient temperature-controlled irrigated ablation. We sought to assess the 1-year clinical safety and efficacy of the DT catheter in treating drug-refractory paroxysmal AF. Methods The TRAC-AF trial (NCT02821351) is a prospective, multi-center (n = 4), single-arm study which enrolled patients with symptomatic, drug-refractory, paroxysmal AF. Using the DT catheter, point-by-point ablation was performed around all pulmonary veins (PVs) to achieve PV isolation (PVI). Ablation was performed in a temperature-controlled mode (60 degrees C, max 50 W). Acute and chronic efficacy and safety was evaluated. Results Seventy-one patients (age 69.9 +/- 11.0 years; 60.6% male) were ablated using the DT catheter. The mean fluoroscopy and RF ablation times were 9.3 +/- 6.1 min and 20.6 +/- 8.9 min, respectively. Acute isolation of all PVs was achieved in 100% of patients, and freedom from AF after 1 year was 70.6%. There were no steam pops, char, or coagulum on the catheter tip after ablation. There were few serious procedure/device-related adverse events including a single case of cardiac tamponade (1.4%) and transient ischemic attack (1.4). Conclusion This first inman series demonstrates that temperature-controlled irrigated RFA with the DT catheter is efficient, safe, and effective in the treatment of paroxysmal AF. Randomized controlled trials are ongoing and will evaluate better the role of this catheter in relation to standard RFA.
VytisknoutZobrazeno: 22. 7. 2024 07:20